Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
BMJ Open|March 30, 2018
Electroacupuncture plus standard of care for managing refractory functional dyspepsia: protocol of a pragmatic trial with economic evaluationVincent C H Chung, Charlene H L Wong, Jessica Y L Ching, et al.
Frontiers in Pharmacology|April 18, 2022
A Chinese Medicine Formula (Bushen Huoxue Tongluo) for the Treatment of Chronic Subjective Tinnitus: A Study Protocol for a Pilot, Assessor-Blinded, Randomized Clinical TrialHong Wei Zhang, Kammy N K Yeung, Michael C F Tong, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 2, 2017
Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control studyTsz-Tai Chan, William Chun-Yin Leung, Victor Li, et al.
Frontiers in Pharmacology|January 23, 2024
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine-study protocol for a randomized, double-blind, placebo-controlled trialChi Him Sum, Tong Wendy Li, Hongwei Zhang, et al.
Frontiers in Pharmacology|September 25, 2023
Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trialHong Wei Zhang, Kammy N K Yeung, Michael C F Tong, et al.
Respiratory Medicine|September 12, 2020
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemicKing Pui Florence Chan, Ting Fung Ma, Wang Chun Kwok, et al.
Frontiers in Medicine|January 23, 2023
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)-A double-blind, randomized, and placebo-controlled clinical trial protocolChi Him Sum, Jessica Yuet Ling Ching, Tianhe Song, et al.
Molecular Autism|January 4, 2018
Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autismKit San Yeung, Winnie Wan Yee Tso, Janice Jing Kun Ip, et al.
Chinese Medicine|July 22, 2022
Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled studyHing Yu Hung, Tianhe Song, Steven King Fan Loo, et al.
Frontiers in Pharmacology|January 2, 2023
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trialPui Kuan Cheong, Tin Muk Ho, Kam Leung Chan, et al.
Pageof 4